Kathleen S Whelan, | |
955 Saint Peters Church Rd, Chapin, SC 29036-8197 | |
(904) 553-1203 | |
Not Available |
Full Name | Kathleen S Whelan |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 955 Saint Peters Church Rd, Chapin, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417419722 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kathleen S Whelan, 700 Woodrow St Unit 109, Columbia, SC 29205-1770 Ph: () - | Kathleen S Whelan, 955 Saint Peters Church Rd, Chapin, SC 29036-8197 Ph: (904) 553-1203 |
News Archive
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
Boehringer Ingelheim Pharmaceuticals, Inc. today reported preliminary results from the randomized Phase II part of a Phase I/II study involving the company's investigational compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy.
The first study into the prevalence of overall cardiovascular risk in the Spanish working population shows that 6% of workers have a high risk. This prevalence increases with age in both sexes, and is highest in the farming sector, followed by construction, industry and services.
Pregnant women, infants and young children should avoid raw or unpasteurized milk and milk products and only consume pasteurized products, according to a new policy statement from the American Academy of Pediatrics.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 3 days ago
Mrs. Janice Acquisto, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1531 Three Dog Rd, Chapin, SC 29036 Phone: 803-476-4600 | |
Monica Locascio, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 444 Crawley Ln, Chapin, SC 29036 Phone: 631-786-9756 | |
Abbi Katherine Dowell, M.S. SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 814 Amicks Ferry Rd, Chapin, SC 29036 Phone: 803-756-1100 | |
Mrs. Kimberly Mccartha Santiago, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 963 Westwoods Dr, Chapin, SC 29036 Phone: 803-345-7710 | |
Pleshette Johnson Kelly, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 128 Stoney Point Ln, Chapin, SC 29036 Phone: 520-576-6795 | |
Stacey Ailes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 128 Stoney Point Ln, Chapin, SC 29036 Phone: 803-622-7939 Fax: 803-708-8725 | |
Mrs. Dawn Victoira Zaffiro, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 548 Village Church Dr, Chapin, SC 29036 Phone: 803-446-0432 |